1.
Husham A. Aldaoseri, Naael Hussein Ali, Fires Al-Mubarak. The effect of biological anti-TNF-α therapy, originator and biosimilar, used to treat ankylosing spondylitis was studied based on clinical and blood counts and an inflammatory marker. J Popl Ther Clin Pharmacol [Internet]. 2023 Apr. 27 [cited 2024 Nov. 18];30(5):615-20. Available from: https://mail.jptcp.com/index.php/jptcp/article/view/1708